Ceribell, Inc. (CBLL)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · CBLL
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Results of Operations and Financial Condition. On August 10, 2026, CeriBell, Inc. issued a press release announcing its financial results for the fiscal quarter ended June 30, 2026. A copy of the press release, dated August 10, 2026, is furnished hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing information in this Item 2.02 (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall…
Director — William W. Burke, Joseph M. Taylor: The resignations and re-elections of Mr. Burke and Mr. Taylor were effected solely to rebalance the Board’s classes.
Results of Operations and Financial Condition. On May 11, 2026, CeriBell, Inc. issued a press release announcing its financial results for the fiscal quarter ended March 31, 2026. A copy of the press release, dated May 11, 2026, is furnished hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing information in this Item 2.02 (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be…
Results of Operations and Financial Condition. On February 24, 2026, CeriBell, Inc. issued a press release announcing its financial results for the fiscal quarter ended December 31, 2025. A copy of the press release, dated February 24, 2026, is furnished hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing information in this Item 2.02 (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, no…
Chair of the Nominating and Corporate Governance Committee, Director — Lucian Iancovici: Resigned from the Board and related positions.
Entry into a Material Definitive Agreement. On December 11, 2025, Ceribell, Inc. (the “Company”) and George Yagmourian and Josefa Yagmourian, Trustees of the Yagmourian 1984 Living Trust (the “625 Lessor”), entered into the Second Amendment, effective December 4, 2025 (the “625 Amendment”), to the Standard Industrial/Commercial Multi-Tenant Lease dated May 17, 2024 (the “Original 625 Lease,” and as amended, the “625 Lease”). The 625 Lease covers approximately 11,607 square feet of office spac…
Results of Operations and Financial Condition. On November 4, 2025, Ceribell, Inc. issued a press release announcing its financial results for the fiscal quarter ended September 30, 2025. A copy of the press release, dated November 4, 2025, is furnished hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing information in this Item 2.02 (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor…
Entry into a Material Definitive Agreement. Ceribell, Inc. (the “Company”) and Shenzhen Everwin Precision Technology Co., Ltd. (“Everwin China”) are parties to the Corporate Supply Agreement, dated January 10, 2022, as amended by Amendment No. 1, dated March 7, 2023, and Amendment No. 2, dated November 28, 2023 (collectively, the “Supply Agreement”). Pursuant to the Supply Agreement, which had an initial term of two years, Everwin China and its Affiliates (as defined in the Supply Agreement)…
Director — Erica Rogers: Erica Rogers was elected as a director and appointed to the Compensation Committee.
Results of Operations and Financial Condition. On August 5, 2025, Ceribell, Inc. issued a press release announcing its financial results for the fiscal quarter ended June 30, 2025. A copy of the press release, dated August 5, 2025, is furnished hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing information in this Item 2.02 (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it…
Entry into a Material Definitive Agreement. Ceribell, Inc. (the “Company”) and The Board of Trustees of the Leland Stanford Junior University (“Stanford”) are parties to an Exclusive (Equity) Agreement, effective June 15, 2015, as amended by Amendment No. 1 effective September 9, 2015, Amendment No. 2 effective April 1, 2017, and Amendment No. 3 effective March 8, 2022 (collectively, the “Stanford Agreement”). Pursuant to the Stanford Agreement, Stanford granted to the Company a worldwide, te…
Results of Operations and Financial Condition. On May 8, 2025, Ceribell, Inc. issued a press release announcing its financial results for the fiscal quarter ended March 31, 2025. A copy of the press release, dated May 8, 2025, is furnished hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing information in this Item 2.02 (including the exhibit hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall i…
Regulation FD Disclosure. The U.S. government has recently announced a broad range of tariffs (“incremental tariffs”) on goods imported into the United States. In response to apparent market uncertainty, CeriBell, Inc. (“Ceribell” or the “Company”) is providing estimates to clarify the potential impact from these incremental tariffs on the cost of goods sourced from its two contract manufacturers in China. These contractors manufacture and assemble Ceribell’s headband product, with final qual…
Compensation adjustments for senior executives were approved.
Results of Operations and Financial Condition. On February 25, 2025, Ceribell, Inc. issued a press release announcing its financial results for the fiscal quarter ended December 31, 2024. A copy of the press release, dated February 25, 2025, is furnished hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing information in this Item 2.02 (including the exhibit hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amend…
Results of Operations and Financial Condition. On November 12, 2024, the Company issued a press release announcing its financial results for the fiscal quarter ended September 30, 2024. A copy of the press release, dated November 12, 2024, is furnished hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing information in this Item 2.02 (including the exhibit hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.